Amicrobe
Macro Biologics is dedicated to designing, patenting, and producing macro biologics—robust biological polymers with physical properties and functional activities that are safe for humans and the environment. They focus on creating innovative products across multiple industries, including therapeutics, food packaging, and healthcare, inspired by natural macro biologics like cellulose and collagen. Their mission is to address global problems such as antibiotic resistance and pollution by developing synthetic macro biologics that are sustainable and beneficial.
Industries
Nr. of Employees
small (1-50)
Amicrobe
3142 Tiger Run Court - Suite 101, Carlsbad, California 92010
Patents
Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety
US-12268722-B2
View DetailsCompositions and uses of antimicrobial materials with tissue-compatible properties
US-12016898-B2
View DetailsCompositions and uses of antimicrobial materials with tissue-compatible properties
US-11298401-B2
View DetailsCompositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety
US-11285189-B2
View DetailsCompositions and uses of antimicrobial materials with tissue-compatible properties
US-9446090-B2
View Details
Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety
US-12268722-B2
View DetailsCompositions and uses of antimicrobial materials with tissue-compatible properties
US-12016898-B2
View DetailsCompositions and uses of antimicrobial materials with tissue-compatible properties
US-11298401-B2
View DetailsCompositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety
US-11285189-B2
View DetailsCompositions and uses of antimicrobial materials with tissue-compatible properties
US-9446090-B2
View DetailsProducts
Topical surgical gel (investigational antimicrobial polymer)
An investigational polymer-based topical gel designed to prevent surgical and traumatic wound infections through local antimicrobial action and biocompatible formulation.
Topical antimicrobial solution for contaminated/infected tissues (investigational)
An investigational polymer-based solution intended to treat contaminated or infected tissues with local antimicrobial activity.
Prolonged field-care formulation for military and austere settings (investigational)
A lead clinical formulation selected for prolonged field care applications to treat or prevent wound infections in military or austere environments.
Topical surgical gel (investigational antimicrobial polymer)
An investigational polymer-based topical gel designed to prevent surgical and traumatic wound infections through local antimicrobial action and biocompatible formulation.
Topical antimicrobial solution for contaminated/infected tissues (investigational)
An investigational polymer-based solution intended to treat contaminated or infected tissues with local antimicrobial activity.
Prolonged field-care formulation for military and austere settings (investigational)
A lead clinical formulation selected for prolonged field care applications to treat or prevent wound infections in military or austere environments.
Services
Collaborative R&D and development programs to adapt synthetic polymer biologic technology for customer product goals across healthcare, skin care, consumer health, and environmental uses.
Design and management of nonclinical pharmacology and GLP toxicology programs, plus regulatory interactions to support IND preparation and submissions.
Support for GMP production of synthetic biologic polymers, including vendor selection, oversight of contract manufacturing, and clinical supply chain management.
Collaborative R&D and development programs to adapt synthetic polymer biologic technology for customer product goals across healthcare, skin care, consumer health, and environmental uses.
Design and management of nonclinical pharmacology and GLP toxicology programs, plus regulatory interactions to support IND preparation and submissions.
Support for GMP production of synthetic biologic polymers, including vendor selection, oversight of contract manufacturing, and clinical supply chain management.
Expertise Areas
- Antimicrobial biomaterials development
- Polymer synthesis and scale-up (biologic polymers)
- GMP manufacturing for clinical biologics
- Preclinical development and GLP toxicology
Key Technologies
- Amino-acid-based block copolymers
- Synthetic biological polymers
- Polymer synthesis and characterization
- GMP biomanufacturing
News & Updates
Macro Biologics announced an investment from Impact Foundation, a charity that supports companies pursuing economic, social, and spiritual transformation.
Macro Biologics will attend and present at the World Antimicrobial Resistance Congress 2024, focusing on protecting gateways against microbial invasion.
Macro Biologics entered a multi-year partnership with Beiersdorf to develop biodegradable antimicrobial peptides for skin care and healthcare, with Beiersdorf also becoming an investor.
Macro Biologics announced an investment from Impact Foundation, a charity that supports companies pursuing economic, social, and spiritual transformation.
Amicrobe, Inc. changed its name to Macro Biologics to better reflect its broad technology platform and business approach.
Amicrobe develops novel antimicrobial products, including Amicidin-α Surgical Gel and Amicidin-β Solution, to prevent and treat infections, supported by various government agencies.
Macro Biologics announced an investment from Impact Foundation, a charity that supports companies pursuing economic, social, and spiritual transformation.
Macro Biologics will attend and present at the World Antimicrobial Resistance Congress 2024, focusing on protecting gateways against microbial invasion.
Macro Biologics entered a multi-year partnership with Beiersdorf to develop biodegradable antimicrobial peptides for skin care and healthcare, with Beiersdorf also becoming an investor.
Macro Biologics announced an investment from Impact Foundation, a charity that supports companies pursuing economic, social, and spiritual transformation.
Amicrobe, Inc. changed its name to Macro Biologics to better reflect its broad technology platform and business approach.
Amicrobe develops novel antimicrobial products, including Amicidin-α Surgical Gel and Amicidin-β Solution, to prevent and treat infections, supported by various government agencies.